Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3519-3525, September 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verma, A. K.
Right arrow Articles by Boutwell, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verma, A. K.
Right arrow Articles by Boutwell, R. K.

Differential Effects of Retinoic Acid and 7,8-Benzoflavone on the Induction of Mouse Skin Tumors by the Complete Carcinogenesis Process and by the Initiation-Promotion Regimen1

Ajit K. Verma2, Elizabeth A. Conrad and R. K. Boutwell

Division of Clinical Oncology, Department of Human Oncology, Wisconsin Clinical Cancer Center [A. K. V.], and McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706 [E. A. C., R. K. B.]

The present study was designed to elucidate differences in the mechanism of the induction of mouse skin tumors either by the initiation-promotion regimen or by the complete carcinogenesis process. The protocols used to elicit skin tumors were: (a) by the initiation-promotion regimen, a single application of 0.2 µmol of 7,12-dimethylbenz[a]anthracene (DMBA) followed by twice-weekly applications of 12-O-tetradecanoylphorbol-13-acetate (TPA); and (b) by the complete carcinogenesis process, a single application of 3.2 µmol of DMBA without TPA treatment, or 0.2 µmol of DMBA applied once weekly, or 1, 10, 50, or 100 nmol of DMBA applied twice weekly without application of TPA. The biology of tumor formation by the initiation of tumors with a single application of 0.2 µmol of DMBA followed by twice-weekly applications of TPA differs from tumor induction by once-weekly 0.2-µmol doses of DMBA. In the latter case, papillomas developed more slowly and were less common (the tumor induction time was long; tumor yield was less), but carcinomas appeared much earlier. Retinoic acid, a potent inhibitor of tumor promotion by TPA, failed to inhibit and under some experimental conditions significantly (p < 0.001) enhanced tumor formation by DMBA. Also, retinoic acid did not inhibit ornithine decarboxylase induction by DMBA. In contrast, 7,8-benzoflavone, which did not inhibit the induction of ornithine decarboxylase activity by TPA, inhibited the induction of ornithine decarboxylase activity and tumor formation by DMBA.

The results indicate that the nature and the mechanism of the biochemical events elicited by the presumed promoting component of carcinogenesis by a complete carcinogen are different from those of the tumor promoter TPA.

1 This work was supported by Grants CA-07175 and CA-22484 from NIH.

2 To whom requests for reprints should be addressed, at the Department of Human Oncology, Wisconsin Clinical Cancer Center, University of Wisconsin Center for Health Sciences K4/538, 600 Highland Avenue, Madison, Wis. 53792.

Received 12/10/81. Accepted 5/28/82.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. T. Schug, D. C. Berry, I. A. Toshkov, L. Cheng, A. Y. Nikitin, and N. Noy
Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPAR{beta}/{delta} to RAR
PNAS, May 27, 2008; 105(21): 7546 - 7551.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H. Aziz, D. L. Wheeler, B. Bhamb, and A. K. Verma
Protein Kinase C {delta} Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation-Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
Cancer Res., January 15, 2006; 66(2): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. P. Jansen, E. G. Verwiebe, N. E. Dreckschmidt, D. L. Wheeler, T. D. Oberley, and A. K. Verma
Protein Kinase C-{{epsilon}} Transgenic Mice: A Unique Model for Metastatic Squamous Cell Carcinoma
Cancer Res., February 1, 2001; 61(3): 808 - 812.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
P. J. Reddig, N. E. Dreckschmidt, J. Zou, S. E. Bourguignon, T. D. Oberley, and A. K. Verma
Transgenic Mice Overexpressing Protein Kinase C{{epsilon}} in Their Epidermis Exhibit Reduced Papilloma Burden but Enhanced Carcinoma Formation after Tumor Promotion
Cancer Res., February 1, 2000; 60(3): 595 - 602.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.